- Home
- Publications
- Publication Search
- Publication Details
Title
Clinical significance of post-progression survival in lung cancer
Authors
Keywords
-
Journal
Thoracic Cancer
Volume 8, Issue 5, Pages 379-386
Publisher
Wiley
Online
2017-06-19
DOI
10.1111/1759-7714.12463
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Clinical Significance of the Relationship between Progression-Free Survival or Postprogression Survival and Overall Survival in Patients with Extensive Disease-Small-Cell Lung Cancer Treated with Carboplatin plus Etoposide
- (2016) Hisao Imai et al. Canadian Respiratory Journal
- Association between time to progression and subsequent survival inceritinib-treated patients with advanced ALK-positive non-small-cell lung cancer
- (2016) Geoffrey Liu et al. CURRENT MEDICAL RESEARCH AND OPINION
- Clinical impact of post-progression survival on overall survival in elderly patients with extensive disease small-cell lung cancer
- (2016) Hisao Imai et al. Thoracic Cancer
- Verification of the Correlation between Progression-free Survival and Overall Survival Considering Magnitudes of Survival Post-progression in the Treatment of Four Types of Cancer
- (2015) Li-Ya Liu et al. Asian Pacific Journal of Cancer Prevention
- Clinical impact of postprogression survival for overall survival in elderly patients (aged 75 years or older) with advanced nonsmall cell lung cancer
- (2015) Hisao Imai et al. Journal of Cancer Research and Therapeutics
- Multitrial Evaluation of Progression-Free Survival as a Surrogate End Point for Overall Survival in First-Line Extensive-Stage Small-Cell Lung Cancer
- (2015) Nathan R. Foster et al. Journal of Thoracic Oncology
- Post-Progression Survival after EGFR-TKI for Advanced Non-Small Cell Lung Cancer Harboring EGFR Mutations
- (2015) Yoshihito Kogure et al. PLoS One
- Relationship between progression-free survival and overall survival in patients with advanced non-small cell lung cancer treated with anticancer agents after first-line treatment failure
- (2014) Hidekazu Suzuki et al. Asia-Pacific Journal of Clinical Oncology
- Progression-free survival as an end-point in solid tumours – Perspectives from clinical trials and clinical practice
- (2014) Andrew G. Robinson et al. EUROPEAN JOURNAL OF CANCER
- Why post-progression survival and post-relapse survival are not appropriate measures of efficacy in cancer randomized clinical trials
- (2014) Xabier García-Albéniz et al. INTERNATIONAL JOURNAL OF CANCER
- Individual-level data on the relationships of progression-free survival and post-progression survival with overall survival in patients with advanced non-squamous non-small cell lung cancer patients who received second-line chemotherapy
- (2014) Hisao Imai et al. MEDICAL ONCOLOGY
- Surrogate End Points and Postprogression Survival in Renal Cell Carcinoma: An Analysis of First-Line Trials With Targeted Therapies
- (2013) Fausto Petrelli et al. Clinical Genitourinary Cancer
- Postprogression survival for first-line chemotherapy in patients with advanced gastric cancer
- (2013) Hisato Kawakami et al. EUROPEAN JOURNAL OF CANCER
- Progression-free survival and post-progression survival in patients with advanced gastric cancer treated with first-line chemotherapy
- (2013) Kohei Shitara et al. JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY
- Post-Progression Survival in Patients with Non-Small Cell Lung Cancer with Clinically Acquired Resistance to Gefitinib
- (2013) Hyojeong Kim et al. JOURNAL OF KOREAN MEDICAL SCIENCE
- Surrogate endpoints for overall survival in chemotherapy and radiotherapy trials in operable and locally advanced lung cancer: a re-analysis of meta-analyses of individual patients' data
- (2013) Audrey Mauguen et al. LANCET ONCOLOGY
- Prediction of survival benefits from progression-free survival benefits in advanced non-small-cell lung cancer: evidence from a meta-analysis of 2334 patients from 5 randomised trials
- (2013) Silvy Laporte et al. BMJ Open
- Correlation of progression-free and post-progression survival with overall survival in advanced colorectal cancer
- (2012) F. Petrelli et al. ANNALS OF ONCOLOGY
- Cancer statistics, 2012
- (2012) Rebecca Siegel et al. CA-A CANCER JOURNAL FOR CLINICIANS
- Postprogression Survival in Patients With Advanced Non–Small-Cell Lung Cancer Who Receive Second-Line or Third-Line Chemotherapy
- (2012) Hidetoshi Hayashi et al. Clinical Lung Cancer
- Postprogression survival for first-line chemotherapy of patients with advanced non-small-cell lung cancer
- (2011) H. Hayashi et al. ANNALS OF ONCOLOGY
- A systematic review evaluating the relationship between progression free survival and post progression survival in advanced ovarian cancer
- (2011) Sudha Sundar et al. GYNECOLOGIC ONCOLOGY
- Surrogacy of tumor response and progression-free survival for overall survival in metastatic breast cancer resistant to both anthracyclines and taxanes
- (2011) Yoshihiro Matsubara et al. International Journal of Clinical Oncology
- Role of Survival Post-Progression in Phase III Trials of Systemic Chemotherapy in Advanced Non-Small-Cell Lung Cancer: A Systemic Review
- (2011) Katsuyuki Hotta et al. PLoS One
- Should progression-free survival be the primary measure of efficacy for advanced NSCLC therapy?
- (2010) J. C. Soria et al. ANNALS OF ONCOLOGY
- Tumor response and progression-free survival as potential surrogate endpoints for overall survival in extensive stage small-cell lung cancer
- (2010) Nathan R. Foster et al. CANCER
- Overall Survival and Post-Progression Survival in Advanced Breast Cancer: A Review of Recent Randomized Clinical Trials
- (2010) Everardo D. Saad et al. JOURNAL OF CLINICAL ONCOLOGY
- Time to Progression as a Surrogate Marker for Overall Survival in Patients with Advanced Non-small Cell Lung Cancer
- (2010) Katsuyuki Hotta et al. Journal of Thoracic Oncology
- Phase III Trial of Cisplatin Plus Gemcitabine With Either Placebo or Bevacizumab As First-Line Therapy for Nonsquamous Non–Small-Cell Lung Cancer: AVAiL
- (2009) Martin Reck et al. JOURNAL OF CLINICAL ONCOLOGY
- Detecting an Overall Survival Benefit that Is Derived From Progression-Free Survival
- (2009) Kristine R. Broglio et al. JNCI-Journal of the National Cancer Institute
- Progression-free survival and time to progression as primary end points in advanced breast cancer: often used, sometimes loosely defined
- (2008) E. D. Saad et al. ANNALS OF ONCOLOGY
- Use of progression-free survival as a surrogate marker in oncology trials: some regulatory issues
- (2008) Aloka Chakravarty et al. STATISTICAL METHODS IN MEDICAL RESEARCH
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now